nodes	percent_of_prediction	percent_of_DWPC	metapath
Icosapent ethyl—DGAT1—Triacylglyceride Synthesis—LIPC—focal segmental glomerulosclerosis	0.102	0.245	CbGpPWpGaD
Icosapent ethyl—DGAT1—Statin Pathway—LIPC—focal segmental glomerulosclerosis	0.0874	0.211	CbGpPWpGaD
Icosapent ethyl—DGAT1—nephron tubule—focal segmental glomerulosclerosis	0.0791	0.539	CbGeAlD
Icosapent ethyl—DGAT1—cortex of kidney—focal segmental glomerulosclerosis	0.0677	0.461	CbGeAlD
Icosapent ethyl—DGAT1—Triacylglyceride Synthesis—LPL—focal segmental glomerulosclerosis	0.0621	0.15	CbGpPWpGaD
Icosapent ethyl—DGAT1—Statin Pathway—LPL—focal segmental glomerulosclerosis	0.0534	0.129	CbGpPWpGaD
Icosapent ethyl—DGAT1—Vitamin A and Carotenoid Metabolism—LPL—focal segmental glomerulosclerosis	0.0389	0.0939	CbGpPWpGaD
Icosapent ethyl—Tendon disorder—Cyclosporine—focal segmental glomerulosclerosis	0.0374	0.0854	CcSEcCtD
Icosapent ethyl—Rheumatoid arthritis—Cyclosporine—focal segmental glomerulosclerosis	0.0324	0.0738	CcSEcCtD
Icosapent ethyl—DGAT1—Fatty acid, triacylglycerol, and ketone body metabolism—CTGF—focal segmental glomerulosclerosis	0.0179	0.0431	CbGpPWpGaD
Icosapent ethyl—Polyp—Cyclosporine—focal segmental glomerulosclerosis	0.0161	0.0366	CcSEcCtD
Icosapent ethyl—Cyst—Cyclosporine—focal segmental glomerulosclerosis	0.0146	0.0333	CcSEcCtD
Icosapent ethyl—Hyperlipidaemia—Cyclosporine—focal segmental glomerulosclerosis	0.0136	0.0309	CcSEcCtD
Icosapent ethyl—Fungal infection—Cyclosporine—focal segmental glomerulosclerosis	0.0127	0.0289	CcSEcCtD
Icosapent ethyl—Viral infection—Cyclosporine—focal segmental glomerulosclerosis	0.0108	0.0247	CcSEcCtD
Icosapent ethyl—DGAT1—Fatty acid, triacylglycerol, and ketone body metabolism—AGT—focal segmental glomerulosclerosis	0.0106	0.0255	CbGpPWpGaD
Icosapent ethyl—Cataract—Cyclosporine—focal segmental glomerulosclerosis	0.0103	0.0234	CcSEcCtD
Icosapent ethyl—Eructation—Cyclosporine—focal segmental glomerulosclerosis	0.0096	0.0219	CcSEcCtD
Icosapent ethyl—Fluid retention—Cyclosporine—focal segmental glomerulosclerosis	0.00928	0.0212	CcSEcCtD
Icosapent ethyl—Neoplasm—Cyclosporine—focal segmental glomerulosclerosis	0.00883	0.0202	CcSEcCtD
Icosapent ethyl—Lymphadenopathy—Cyclosporine—focal segmental glomerulosclerosis	0.00831	0.019	CcSEcCtD
Icosapent ethyl—DGAT1—Metabolism of lipids and lipoproteins—LIPC—focal segmental glomerulosclerosis	0.00808	0.0195	CbGpPWpGaD
Icosapent ethyl—Gastroenteritis—Cyclosporine—focal segmental glomerulosclerosis	0.008	0.0183	CcSEcCtD
Icosapent ethyl—Eczema—Cyclosporine—focal segmental glomerulosclerosis	0.00789	0.018	CcSEcCtD
Icosapent ethyl—Increased appetite—Cyclosporine—focal segmental glomerulosclerosis	0.00755	0.0172	CcSEcCtD
Icosapent ethyl—Arthritis—Cyclosporine—focal segmental glomerulosclerosis	0.0073	0.0167	CcSEcCtD
Icosapent ethyl—DGAT1—Metabolism of lipids and lipoproteins—CTGF—focal segmental glomerulosclerosis	0.00712	0.0172	CbGpPWpGaD
Icosapent ethyl—Migraine—Cyclosporine—focal segmental glomerulosclerosis	0.00698	0.0159	CcSEcCtD
Icosapent ethyl—Affect lability—Cyclosporine—focal segmental glomerulosclerosis	0.00698	0.0159	CcSEcCtD
Icosapent ethyl—Mood swings—Cyclosporine—focal segmental glomerulosclerosis	0.00672	0.0153	CcSEcCtD
Icosapent ethyl—Gastritis—Cyclosporine—focal segmental glomerulosclerosis	0.00628	0.0143	CcSEcCtD
Icosapent ethyl—Abdominal distension—Cyclosporine—focal segmental glomerulosclerosis	0.00617	0.0141	CcSEcCtD
Icosapent ethyl—Dysphagia—Cyclosporine—focal segmental glomerulosclerosis	0.00613	0.014	CcSEcCtD
Icosapent ethyl—Pancreatitis—Cyclosporine—focal segmental glomerulosclerosis	0.00601	0.0137	CcSEcCtD
Icosapent ethyl—Bronchitis—Cyclosporine—focal segmental glomerulosclerosis	0.0059	0.0135	CcSEcCtD
Icosapent ethyl—Hyperglycaemia—Cyclosporine—focal segmental glomerulosclerosis	0.00553	0.0126	CcSEcCtD
Icosapent ethyl—Pneumonia—Cyclosporine—focal segmental glomerulosclerosis	0.0055	0.0125	CcSEcCtD
Icosapent ethyl—Infestation NOS—Cyclosporine—focal segmental glomerulosclerosis	0.00547	0.0125	CcSEcCtD
Icosapent ethyl—Infestation—Cyclosporine—focal segmental glomerulosclerosis	0.00547	0.0125	CcSEcCtD
Icosapent ethyl—Acute coronary syndrome—Cyclosporine—focal segmental glomerulosclerosis	0.00539	0.0123	CcSEcCtD
Icosapent ethyl—Myocardial infarction—Cyclosporine—focal segmental glomerulosclerosis	0.00536	0.0122	CcSEcCtD
Icosapent ethyl—Epistaxis—Cyclosporine—focal segmental glomerulosclerosis	0.00516	0.0118	CcSEcCtD
Icosapent ethyl—Sinusitis—Cyclosporine—focal segmental glomerulosclerosis	0.00513	0.0117	CcSEcCtD
Icosapent ethyl—DGAT1—Metabolism of lipids and lipoproteins—LPL—focal segmental glomerulosclerosis	0.00493	0.0119	CbGpPWpGaD
Icosapent ethyl—Rhinitis—Cyclosporine—focal segmental glomerulosclerosis	0.00492	0.0112	CcSEcCtD
Icosapent ethyl—Pharyngitis—Cyclosporine—focal segmental glomerulosclerosis	0.00487	0.0111	CcSEcCtD
Icosapent ethyl—Chills—Cyclosporine—focal segmental glomerulosclerosis	0.0044	0.01	CcSEcCtD
Icosapent ethyl—Arrhythmia—Cyclosporine—focal segmental glomerulosclerosis	0.00438	0.01	CcSEcCtD
Icosapent ethyl—Alopecia—Cyclosporine—focal segmental glomerulosclerosis	0.00434	0.00989	CcSEcCtD
Icosapent ethyl—Malnutrition—Cyclosporine—focal segmental glomerulosclerosis	0.00427	0.00975	CcSEcCtD
Icosapent ethyl—DGAT1—Metabolism of lipids and lipoproteins—AGT—focal segmental glomerulosclerosis	0.00422	0.0102	CbGpPWpGaD
Icosapent ethyl—Dysgeusia—Cyclosporine—focal segmental glomerulosclerosis	0.00418	0.00954	CcSEcCtD
Icosapent ethyl—Ill-defined disorder—Cyclosporine—focal segmental glomerulosclerosis	0.00396	0.00904	CcSEcCtD
Icosapent ethyl—Malaise—Cyclosporine—focal segmental glomerulosclerosis	0.00385	0.00879	CcSEcCtD
Icosapent ethyl—Vertigo—Cyclosporine—focal segmental glomerulosclerosis	0.00384	0.00876	CcSEcCtD
Icosapent ethyl—Cough—Cyclosporine—focal segmental glomerulosclerosis	0.00373	0.0085	CcSEcCtD
Icosapent ethyl—Hypertension—Cyclosporine—focal segmental glomerulosclerosis	0.00369	0.00841	CcSEcCtD
Icosapent ethyl—Chest pain—Cyclosporine—focal segmental glomerulosclerosis	0.00364	0.0083	CcSEcCtD
Icosapent ethyl—Myalgia—Cyclosporine—focal segmental glomerulosclerosis	0.00364	0.0083	CcSEcCtD
Icosapent ethyl—Arthralgia—Cyclosporine—focal segmental glomerulosclerosis	0.00364	0.0083	CcSEcCtD
Icosapent ethyl—DGAT1—Metabolism—LIPC—focal segmental glomerulosclerosis	0.0036	0.00868	CbGpPWpGaD
Icosapent ethyl—Discomfort—Cyclosporine—focal segmental glomerulosclerosis	0.00359	0.0082	CcSEcCtD
Icosapent ethyl—Dry mouth—Cyclosporine—focal segmental glomerulosclerosis	0.00356	0.00811	CcSEcCtD
Icosapent ethyl—Anaphylactic shock—Cyclosporine—focal segmental glomerulosclerosis	0.00349	0.00795	CcSEcCtD
Icosapent ethyl—Oedema—Cyclosporine—focal segmental glomerulosclerosis	0.00349	0.00795	CcSEcCtD
Icosapent ethyl—Infection—Cyclosporine—focal segmental glomerulosclerosis	0.00346	0.0079	CcSEcCtD
Icosapent ethyl—Hyperhidrosis—Cyclosporine—focal segmental glomerulosclerosis	0.00337	0.00769	CcSEcCtD
Icosapent ethyl—Anorexia—Cyclosporine—focal segmental glomerulosclerosis	0.00332	0.00758	CcSEcCtD
Icosapent ethyl—DGAT1—Metabolism of lipids and lipoproteins—ALB—focal segmental glomerulosclerosis	0.00324	0.00781	CbGpPWpGaD
Icosapent ethyl—Musculoskeletal discomfort—Cyclosporine—focal segmental glomerulosclerosis	0.00318	0.00725	CcSEcCtD
Icosapent ethyl—DGAT1—Metabolism—CTGF—focal segmental glomerulosclerosis	0.00317	0.00764	CbGpPWpGaD
Icosapent ethyl—Insomnia—Cyclosporine—focal segmental glomerulosclerosis	0.00315	0.00719	CcSEcCtD
Icosapent ethyl—Dyspnoea—Cyclosporine—focal segmental glomerulosclerosis	0.00311	0.00709	CcSEcCtD
Icosapent ethyl—Dyspepsia—Cyclosporine—focal segmental glomerulosclerosis	0.00307	0.007	CcSEcCtD
Icosapent ethyl—Decreased appetite—Cyclosporine—focal segmental glomerulosclerosis	0.00303	0.00691	CcSEcCtD
Icosapent ethyl—Gastrointestinal disorder—Cyclosporine—focal segmental glomerulosclerosis	0.00301	0.00687	CcSEcCtD
Icosapent ethyl—Pain—Cyclosporine—focal segmental glomerulosclerosis	0.00298	0.0068	CcSEcCtD
Icosapent ethyl—Constipation—Cyclosporine—focal segmental glomerulosclerosis	0.00298	0.0068	CcSEcCtD
Icosapent ethyl—DGAT1—Metabolism—GNAQ—focal segmental glomerulosclerosis	0.00292	0.00704	CbGpPWpGaD
Icosapent ethyl—Feeling abnormal—Cyclosporine—focal segmental glomerulosclerosis	0.00287	0.00655	CcSEcCtD
Icosapent ethyl—Body temperature increased—Cyclosporine—focal segmental glomerulosclerosis	0.00276	0.00629	CcSEcCtD
Icosapent ethyl—Asthenia—Cyclosporine—focal segmental glomerulosclerosis	0.0025	0.00571	CcSEcCtD
Icosapent ethyl—Pruritus—Cyclosporine—focal segmental glomerulosclerosis	0.00247	0.00563	CcSEcCtD
Icosapent ethyl—Dizziness—Cyclosporine—focal segmental glomerulosclerosis	0.00231	0.00526	CcSEcCtD
Icosapent ethyl—Vomiting—Cyclosporine—focal segmental glomerulosclerosis	0.00222	0.00506	CcSEcCtD
Icosapent ethyl—Rash—Cyclosporine—focal segmental glomerulosclerosis	0.0022	0.00501	CcSEcCtD
Icosapent ethyl—DGAT1—Metabolism—LPL—focal segmental glomerulosclerosis	0.0022	0.00529	CbGpPWpGaD
Icosapent ethyl—Dermatitis—Cyclosporine—focal segmental glomerulosclerosis	0.0022	0.00501	CcSEcCtD
Icosapent ethyl—DGAT1—Metabolism—AGT—focal segmental glomerulosclerosis	0.00188	0.00453	CbGpPWpGaD
Icosapent ethyl—DGAT1—Metabolism—ALB—focal segmental glomerulosclerosis	0.00144	0.00348	CbGpPWpGaD
